Evonik launches Innovation Factory – building what’s next for the industry
Evonik transforms strategic research into an agile innovation unit; Focus on combinatorial innovation: connecting internal expertise with external partners. ... MORE
Evonik transforms strategic research into an agile innovation unit; Focus on combinatorial innovation: connecting internal expertise with external partners. ... MORE
Evonik announced the global launch of SPHINOX® Vively, an advanced designer sphingolipid engineered to elevate skin vitality through a unique synergy of biotechnology, barrier science, and high‑performance efficacy. ... MORE
Evonik Catalysts has launched its latest high performance chloride adsorbent, Chlorocel™ 909, confirming the company’s commitment to continued investment in its existing Chlorocel™ product portfolio. ... MORE
Under the theme “The Soul and Science of Beauty”, Evonik will showcase its comprehensive portfolio of innovative, sustainable solutions along with the refreshed visual identity of its Beauty & Personal Care business at PCHi 2026. ... MORE
Evonik has met its profit guidance for 2025 and reaffirmed its outlook for 2026. Outlook 2026 for adjusted EBITDA between €1.7 and €2.0 billion affirmed ... MORE
Evonik is reinforcing its growth strategy by further strengthening its global production infrastructure for hydroxyl-terminated polybutadienes (HTPB). ... MORE